ABSTRACT. To examine the prevalence of autoantibody in canine cerebrospinal fluids (CSFs), CSFs were collected from 14 healthy controls and 88 clinical cases with various diseases in the central nervous system (CNS), and were analyzed by an indirect fluoresc ence antibody test on frozen sections of the cerebrum from normal Beagle dogs. An anti-astrocyte autoantibody was detected in 31 clinica l cases with titers ranging from 1:1 to ≥1:100. All tested cases with necrotizing meningoencephalitis (NME: n=22) and granulomatous meningoencephalitis (GME: n=3) possessed the anti-astrocyte autoantibody, while the autoantibody was negative in most cases with other inflammatory CNS diseases. The autoantibody was also detected in 4 of 12 cases with brain tumors. Hence, examination of the au toantibody in the canine CFS would be significant for diagnosing NME and/or GME, as well as for understanding peritumoral events in cases with brain tumors.
Diagnosis of diseases in the canine central nervous system (CNS) continues to evolve, but there are remaining problems especially with inflammatory diseases. Necrotizing meningoencephalitis (NME: Pug encephalitis) has been reported sporadically in young Pugs [3, 9, 17] and other small-breeds [2, 5, 16] presenting progressive neurological abnormalities such as seizures, ataxia and dementia. Histopathology is characterized by parenchymal necrosis, severe infiltration of mononuclear cells and glial satellitosis in the cerebrum, especially in the subleptomeningeal area. Granulomatous meningoencephalitis (GME) is also an idiopathic CNS disease diagnosed mainly in small breeds [8, 10] . GME is histopathologically characterized by focal or multifocal granulomas and perivascular cuffings with lymphoid cells predominantly in the brainstem. While clinical and histopathological features of NME and GME have been well documented, there is poor information on their pathogenesis. There has been no evidence of causative etiologic agents of NME or GME, although participation of Canine Distemper Virus (CDV) or Canine Herpes Virus (CHV) was suggested [3] .
Autoantibodies have been widely detected in human CNS diseases such as Rasmussen's encephalitis [12] , multiple sclerosis [11] and lupus encephalitis [13, 14] . Recently, Uchida et al. [17] also reported an anti-astrocyte autoantibody in the cerebrospinal fluids (CSFs) from two Pug dogs with NME, suggesting a possibility that NME is an autoimmune disease. In the present study, we examined the prevalence of autoantibody in CSFs from dogs with various CNS diseases including NME and GME.
Eighty-eight dogs referred to the University of Tokyo Veterinary Medical Center for CNS disorders were examined between January 2001 to April 2003. All cases were submitted to neurological examination, complete blood count, serum chemistry and magnetic resonance imaging (MRI). CSFs from the cisterna magna were tested for quantitative and qualitative analyses of cells, glucose and protein concentrations, and microbiological analyses such as Gramstain, bacterial culture, ELISA for CDV-specific antigen, anti-CDV immunoglobulin (IgG) titer, and anti-CHV IgG titer. In a part of cases, postmortem pathological examination was performed to confirm the diagnosis. CSFs from clinically healthy Beagles (1 to 6 year-old, 4 males and 6 females) and Labrador Retrievers (3 to 5 year-old, 3 males and 1 female) were also tested as controls.
Autoantibodies in the CSFs were examined by an indirect fluorescence antibody test (IFA). Briefly, five-micrometer frozen sections from the cerebral occipito-parietal lobes of normal Beagle dogs were dried, fixed with cold acetone, washed in phosphate-buffered saline (PBS), blocked with normal goat serum (1:50), and incubated with CSFs at dilutions of 1:1, 1:10, and/or 1:100 at room temperature for 60 min. After washing, FITC-conjugated goat anti-canine IgG (1:400, Bethyl, Montogomery, TX, U.S.A.) was added for 60 min. Then the slides were washed, mounted with Vectashield (Vector Labs, Burlingame, CA, U.S.A.) and analyzed by a fluorescent microscope (Optiphoto-2, Nikon, Tokyo) equipped with an ORCA-1394 image analyzing system (Hamamatsu Photonics, Hamamatsu). By this IFA, CSFs from 31 cases showed positive reactions on the frozen sections. To identify the target of autoantibody, a doublestaining test was carried out by using a mouse anti-human glial fibrillary acidic protein (GFAP) monoclonal antibody (pre-diluted, YLEM, Roma, Italy) and a rhodamine-conjugated goat anti-murine IgG (1:100, Amersham Biosciences, Piscataway, NJ, U.S.A.) for 1st-and 2nd-antibodies, respectively. Then it was confirmed that all autoantibodies were bound to GFAP-positive astrocytes mainly in the gray matter (Fig. 1) . No other type of autoantibodies such as antineuronal-and antinuclear-antibodies was detected. Serum samples from several cases were also tested by the IFA, however, it was difficult to detect the autoantibody because of the presumable low titer in the blood serum.
The prevalence of the anti-astrocyte autoantibody is shown in Table 1 . NME was diagnosed in 9 Pugs, 6 Pomeranians, 2 Malteses, 2 Yorkshire Terriers, 1 Shih-Tzu, 1 Pekingese and 1 Chihuahua (total n=22). These breeds in our experience well matched to those in previous articles [2, 3, 5, 9, 16, 17] with an exception, Pomeranian. All NME cases possessed the anti-astrocyte autoantibody with titers ranging from 1:1 to ≥1:100. In particular, all of 9 Pugs showed high titers. GME (n=3) was diagnosed in 2 Malteses and a Miniature Dachshund. These cases were of the focal form of GME, and possessed the anti-astrocyte autoantibody with titers from 1:10 to ≥1:100. On the other hand, only one of 11 CDV-infected cases and an case with undiagnosed steroid-responsive encephalitis were positive for the anti-astrocyte antibody with low titers. Four of 12 cases with brain tumors (malignant lymphoma (n=1), malignant histiocytosis (n=1) and undiagnosed brain tumors (n=2)) were also autoantibody-positive with comparatively low titers. There was no autoantibody-positive cases with other CNS diseases.
In the present study, we evaluated the prevalence of autoantibodies in canine CSFs and found that; 1) Only anti- astrocyte autoantibody was detected, 2) Prevalence of the anti-astrocyte autoantibody was highly specific to NME and GME among inflammatory CNS diseases, and 3) the antiastrocyte autoantibody was also detected in cases with brain tumors. We can emphasize that the first point is very unique. While autoantibodies have been widely detected in human inflammatory CNS diseases, the target cells and molecules of those autoantibodies are very variable. Significance of the anti-astrocyte autoantibody in NME is still unclear. Further study is needed to elucidate whether the autoantibody is a cause or a concequence of inflammation. However, Uchida et al. [17] demonstrated that infiltrated mononuclear cells in the cerebrum of Pugs with NME are mainly B lymphocytes and plasma cells, supporting the contribution of humoral immune response in NME. In addition, it is notable that Pugs with NME exhibited higher titers than other breeds. In literatures [3, 9, 17] and our experience, Pugs with NME showed relatively severe clinical courses. There has been also reported a familial NME in Pugs [4] . These data suggest certain breed-related specificity of NME in Pugs, and also indicate a potential etiological involvement of the autoantibody in NME.
In this research, the anti-astrocyte autoantibody was also detected in GME cases, indicating a possible relationship between GME and the autoantibody. Kipar et al. [8] revealed that inflammatory cells in canine GME lesions predominantly consist of CD3-positive lymphocytes and MHC class II-positive macrophages, and then suggested an autoimmune delayed-type hypersensitivity as a possible pathogenesis of GME. Since astrocytes were the common target of autoantibodies both in NME and GME, we can speculate that NME and GME are diverse manifestations associated with a single disease. Apart from the pathogenesis of NME and/or GME, diagnosis of these diseases depends on the postmortem histopathology. We expect that the anti-astrocyte autoantibody could be used as a novel hallmark of NME and/or GME.
In our data, the anti-astrocyte autoantibody was also detected in dogs with intracranial tumors. In human medicine, many types of extracranial tumors are known to cause autoimmune neurological disorders so-called paraneoplastic neurological syndrome [7] , paraneoplastic limbic encephalitis [6] . These disorders are associated with antineuronal autoantibodies, however, target antigens in these disorders are very variable, including so-called Hu, Ma or Ta, which are polyclonal neuronal antigens [6] , and several ion channels [7] . Paraneoplastic cerebellar ataxia is known to possess autoantibod ies against P urkin je cells, while autoantigens have not been identified in most cases with a few exception [15] . On the other hand, there have been very few reports of brain tumors associated with autoantibodies against the CNS. Brunet et al. [1] demonstrated autoantibodies in glioma cyst fluids were reactive to normal CNS cells, suggesting a possible involvement of autoantibodies in certain peritumoral events such as brain edema. In the present study, severe edema and necrosis were observed in the cerebral cortex of a case with malignant histiocytosis, which showed the anti-astrocyte autoantibody with a titer of 1:1. Autoantibodies might result from destruction of the blood brain barrier and/or cross-immunoreactivity of antitumor antibodies against normal astrocytes. There is a possibility that autoantibodies in the CSF modify clinical courses and/or pathological features of brain tumors. Hence, it would be significant to examine antoantibodies from cases with brain tumors, especially if some peritumoral events are found.
In conclusion, the anti-astrocyte autoantibody was found in CSFs of dogs with NME, GME or certain brain tumors. This autoantibody would be helpful for the diagnosis and novel classification of canine CNS diseases.
